首页> 外文期刊>The Botulinum Journal >A pilot trial of onabotulinumtoxinA for the treatment of cervicothoracic myofascial pain
【24h】

A pilot trial of onabotulinumtoxinA for the treatment of cervicothoracic myofascial pain

机译:飞行员onabotulinumtoxinA的审判治疗颈胸的肌筋膜疼痛

获取原文
获取原文并翻译 | 示例
           

摘要

This placebo-controlled crossover trial investigate the safety and efficacy of onabotulinumtoxinA (BOTOX, Allergan, Inc.) for the treatment of cervical myofascial pain syndrome (CMPS). A group of subjects with Cervical Dystonia (CD) served as additional controls. A change in diary pain score from baseline to week 3 in placebo vs. onabotulinumtoxinA was the primary outcome measure. Both CMPS and CD subjects showed a trend towards significant pain relief from onabotulinumtoxinA. This suggests that thestudy was underpowered and that a larger sample size would be necessary in future trials of onabotulinumtoxinA for CMPS.
机译:这安慰剂对照交叉试验调查的安全性和有效性onabotulinumtoxinA(肉毒杆菌,爱力根公司)颈肌筋膜疼痛的治疗综合症(cmp)。颈肌张力障碍(CD)作为附加控制。基线星期3在安慰剂vs。onabotulinumtoxinA是主要的结果衡量。对重要的缓解疼痛onabotulinumtoxinA。动力不足,更大的样本量在今后的试验中是必要的吗onabotulinumtoxinA用于cmp。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号